- RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic…
Number of the records: 1  

RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets?

  1. TitleRAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets? : minireview / P. Tesarova ... [et al.]
    Another responsib. Tesařová, Petra (Author)
    Translated titleRAGE a jeho ligandy v nádore - vinníci, biomarkery alebo terapeutické ciele?: minireview
    Phys.des.ilustr., tab.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 62, no. 3 (2015), s. 353-364
    Call numberC 720
    MeSH Subject nádory - etiológia - metabolizmus - terapia
    produkty pokročilej glykácie, konečné - fyziológia
    receptory imunologické - fyziológia - genetika - antagonisty a inhibítory
    ligandy
    S100 proteíny
    transdukcia signálna
    apoptóza
    biomarkery nádorové
    Keywords receptor for advanced glycation end products (RAGE) * receptor pre koncové produkty pokročilej glykácie
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.